When families come into the clinic, there is a lot of hand-holding, Spizuoco said, to explain the treatments. She recommends ...

Both children and adults can injure their eyes through a bad fall or getting hit in the eye, making awareness of surroundings ...

Access to glucagon-like peptide-1 (GLP-1) receptor agonists for obesity treatment could be expanded through innovative ...

By collaborating with patients from the very start and respecting their unique perspectives, decision-makers can create a ...

A new study 1 found that the use of stereotactic body radiation therapy (SBRT) produced similar overall survival in patients ...

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...

Outbreaks of measles have been seeing an uptick in 2025, which, according to a new review, 1 leads to financial and public health strain in the US. Researchers recommend widespread use of measles ...

Panelists discuss how new dual-targeting agents and TKIs are redefining treatment approaches in EGFR-positive NSCLC.

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Changing the FDA biosimilar interchangeability standards is a necessary but likely insufficient step to improve biosimilar competition in the US.

Arkansas House Bill 1150 aims to protect independent pharmacies but may limit patient access and conflict with federal laws.